Literature DB >> 24613577

Neonatal progeroid variant of Marfan syndrome with congenital lipodystrophy results from mutations at the 3' end of FBN1 gene.

Adeline Jacquinet1, Alain Verloes2, Bert Callewaert3, Christine Coremans4, Paul Coucke3, Anne de Paepe3, Uwe Kornak5, Frederic Lebrun4, Jacques Lombet6, Gérald E Piérard7, Peter N Robinson8, Sofie Symoens3, Lionel Van Maldergem9, François-Guillaume Debray10.   

Abstract

We report a 16-year-old girl with neonatal progeroid features and congenital lipodystrophy who was considered at birth as a possible variant of Wiedemann-Rautenstrauch syndrome. The emergence of additional clinical signs (marfanoid habitus, severe myopia and dilatation of the aortic bulb) lead to consider the diagnosis of the progeroid variant of Marfan syndrome. A de novo donor splice-site mutation (c.8226+1G>A) was identified in FBN1. We show that this mutation leads to exon 64 skipping and to the production of a stable mRNA that should allow synthesis of a truncated profibrillin-1, in which the C-terminal furin cleavage site is altered. FBN1 mutations associated with a similar phenotype have only been reported in four other patients. We confirm the correlation between marfanoid phenotype with congenital lipodystrophy and neonatal progeroid features (marfanoid-progeroid-lipodystrophy syndrome) and frameshift mutations at the 3' end of FBN1. This syndrome should be considered in differential diagnosis of neonatal progeroid syndromes.
Copyright © 2014 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Congenital lipodystrophy; Fibrillinopathy; Marfanoïd features; Neonatal progeria

Mesh:

Substances:

Year:  2014        PMID: 24613577     DOI: 10.1016/j.ejmg.2014.02.012

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  17 in total

Review 1.  Marfanoid-progeroid-lipodystrophy syndrome: a newly recognized fibrillinopathy.

Authors:  Eberhard Passarge; Peter N Robinson; Luitgard M Graul-Neumann
Journal:  Eur J Hum Genet       Date:  2016-02-10       Impact factor: 4.246

2.  Wiedemann-Rautenstrauch syndrome prenatal diagnosis.

Authors:  C H Becerra; G A Contreras-García; L A Perez Vera; L A Díaz-Martínez; M A Beltran Avendaño; H A Salazar Martínez
Journal:  J Perinatol       Date:  2014-12       Impact factor: 2.521

3.  Bi-allelic POLR3A Loss-of-Function Variants Cause Autosomal-Recessive Wiedemann-Rautenstrauch Syndrome.

Authors:  Jennifer A Wambach; Daniel J Wegner; Nivedita Patni; Martin Kircher; Marcia C Willing; Dustin Baldridge; Chao Xing; Anil K Agarwal; Samantha A Schrier Vergano; Chirag Patel; Dorothy K Grange; Amy Kenney; Tasnim Najaf; Deborah A Nickerson; Michael J Bamshad; F Sessions Cole; Abhimanyu Garg
Journal:  Am J Hum Genet       Date:  2018-11-07       Impact factor: 11.025

4.  Asprosin, a Fasting-Induced Glucogenic Protein Hormone.

Authors:  Chase Romere; Clemens Duerrschmid; Juan Bournat; Petra Constable; Mahim Jain; Fan Xia; Pradip K Saha; Maria Del Solar; Bokai Zhu; Brian York; Poonam Sarkar; David A Rendon; M Waleed Gaber; Scott A LeMaire; Joseph S Coselli; Dianna M Milewicz; V Reid Sutton; Nancy F Butte; David D Moore; Atul R Chopra
Journal:  Cell       Date:  2016-04-14       Impact factor: 41.582

Review 5.  Asprosin, a C-Terminal Cleavage Product of Fibrillin 1 Encoded by the FBN1 Gene, in Health and Disease.

Authors:  Mehmet Akif Ovali; Ibrahim Bozgeyik
Journal:  Mol Syndromol       Date:  2022-02-08

Review 6.  Energy Regulation Mechanism and Therapeutic Potential of Asprosin.

Authors:  Jennifer G Hoffmann; Wei Xie; Atul R Chopra
Journal:  Diabetes       Date:  2020-04       Impact factor: 9.461

7.  A Spotlight on Appetite.

Authors:  Lisa R Beutler; Zachary A Knight
Journal:  Neuron       Date:  2018-02-21       Impact factor: 17.173

8.  Expanded spectrum of exon 33 and 34 mutations in SRCAP and follow-up in patients with Floating-Harbor syndrome.

Authors:  Wenke Seifert; Peter Meinecke; Gabriele Krüger; Eva Rossier; Wolfram Heinritz; Achim Wüsthof; Denise Horn
Journal:  BMC Med Genet       Date:  2014-11-30       Impact factor: 2.103

9.  C-terminal propeptide is required for fibrillin-1 secretion and blocks premature assembly through linkage to domains cbEGF41-43.

Authors:  Sacha A Jensen; Georgia Aspinall; Penny A Handford
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-30       Impact factor: 11.205

10.  Expression of FBN1 during adipogenesis: Relevance to the lipodystrophy phenotype in Marfan syndrome and related conditions.

Authors:  Margaret R Davis; Erik Arner; Cairnan R E Duffy; Paul A De Sousa; Ingrid Dahlman; Peter Arner; Kim M Summers
Journal:  Mol Genet Metab       Date:  2016-06-23       Impact factor: 4.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.